GGrantIndex
Sort

39,280 grants matching leukemia

(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies

$321,625
Kristy L Richards · Cornell University · R01 · FY2017 · CA

Targeting the C/EBPalpha-Gfi-pathway in CML stem cells

$321,625
Bruno Calabretta · Thomas Jefferson University · R01 · FY2016 · CA

Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu

$321,625
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2015 · CA

Exploiting Metabloic Defects in Tumors with Mutant IDH1 and IDH2

$321,625
Christian Michael Metallo · University Of California, San Diego · R01 · FY2015 · CA

Exploiting Metabloic Defects in Tumors with Mutant IDH1 and IDH2

$321,625
Christian Michael Metallo · University Of California, San Diego · R01 · FY2018 · CA

Coordination of the actin and microtubule cytoskeletons

$321,600
Bruce L Goode · Brandeis University · R01 · FY2012 · GM

Resistance of CML Stem Cells to Imatinib (Gleevec)

$321,555
Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA

Identification of Methylated Genes in Chronic Lymphocytic Leukemia

$321,545
Christoph Plass · Ohio State University · P01 · FY2008 · CA

NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)

$321,522
Elaine R Mardis · Washington University · U01 · FY2014 · GM

Synergistic Inhibitors of CREB-mediated Gene Transcription

$321,506
Xiangshu Xiao · Oregon Health & Science University · R01 · FY2023 · GM

Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)

$321,500
Jing Zhang · University Of Wisconsin-Madison · R01 · FY2014 · CA

Understanding Retroviral Reverse Transcription, Recombination, and Replication

$321,496
Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Polymorphism of Multi-Drug-Resistance Protein-1

$321,478
University Of Washington · R01 · FY2004 · GM

Immunoglobulin and T Cell Receptor Gene Assembly

$321,464
David G. Schatz · Yale University · R37 · FY2010 · AI

Graft Characterization and Monitoring of Immune Hematopoietic Reconstitution

$321,458
Miguel-Angel Perales · Sloan-Kettering Inst Can Research · P01 · FY2013 · CA

Graft Characterization and Monitoring of Immune Hematopoietic Reconstitution

$321,458
Miguel-Angel Perales · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA

Graft Characterization and Monitoring of Immune Hematopoietic Reconstitution

$321,458
Miguel-Angel Perales · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA

NOVEL GENE REARRANGED WITH THE RAR ALPHA LOCUS

$321,445
Mount Sinai School Of Medicine Of Nyu · R01 · FY2000 · CA

Nuclear Signaling by TRADD

$321,440
Andrew M Thorburn · University Of Colorado Denver · R01 · FY2006 · NS

Cell and Tissue Imaging Shared Resources Core

$321,434
Camenzind G Robinson · St. Jude Children'S Research Hospital · P30 · FY2021 · CA

Transcriptional Control Mechanisms by ETS Factors

$321,425
Barbara J Graves · University Of Utah · R01 · FY2012 · GM

Pathology

$321,393
Sherif S Farag · Ohio State University · P01 · FY2008 · CA

Phase II and Correlative Studies of Bryo/HiDAC

$321,390
Virginia Commonwealth University · R21 · FY2002 · CA

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

$321,373
Dong-Er Zhang · University Of California, San Diego · R01 · FY2019 · CA

Application of 454 Sequencing to Cancer Epigenomics

$321,334
Huidong Shi · Augusta University · R33 · FY2009 · CA